COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon

COVID-19 patients with mild symptoms make a full recovery with no lingering heart issues

Researchers used medical imaging, blood work and advanced AI algorithms to examine patient health six months after a mild COVID-19 infection. 

Thumbnail

COVID-19 may do long-term damage to the heart and blood vessels of young adults

Young adults who had COVID-19—even those who never had strong symptoms—may go on to have significant cardiovascular issues later in life.

Thumbnail

How to diagnose and treat rare blood clots associated with a COVID-19 vaccine

The team behind the new guidance also emphasized how important it still is for all adults to get vaccinated. 

Thumbnail

Cardiologists urge CMS to permanently allow virtual supervision for rehab services

Six healthcare organizations, including the American College of Cardiology and American Heart Association, signed the letter. 

SCAI 2021: COVID-19 especially harmful for high-risk heart attack patients

Researchers presented new data from the North American COVID-19 Myocardial Infarction registry, detailing the ongoing pandemic's "deadly impact." 

Thumbnail

‘The next wave of complications’: Asymptomatic COVID-19 patients face a prolonged stroke risk

The median time from a positive serological test result to acute ischemic stroke was nearly 55 days. 

Football player cleared by cardiologist after missing time due to COVID-related myocarditis

Tommy Sweeney was the first NFL player to come down with myocarditis following a case of COVID-19, missing the rest of the 2020 season after his diagnosis in November.

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

Displaying 201 - 208 of 427

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.